GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...
Vaccines MarketThe global vaccines market is on a robust growth trajectory, projected to rise from USD 42.7 billion in 2023 ...
North America Leads in Revenue Share with Robust Immunization Infrastructure while Asia-Pacific Drives Fastest Growth Fueled ...
GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...
Infectious disease experts on Thursday called for the addition of the vaccine for meningococcal disease, a contagious ...
The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine ...
London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...
The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...
An Adelaide man is in a critical condition in hospital after contracting invasive meningococcal disease, health authorities ...
If you have anything you want to share with us, send us an e-mail at
[email protected]!
GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its meningococcal vaccine, Menveo (MenACWY) for active immunization in children ...